MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 93 filers reported holding MAGENTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $20,746 | -4.6% | 27,369 | 0.0% | 0.00% | – |
Q1 2023 | $21,750 | +101.2% | 27,369 | 0.0% | 0.00% | – |
Q4 2022 | $10,811 | -72.3% | 27,369 | 0.0% | 0.00% | – |
Q3 2022 | $39,000 | -84.9% | 27,369 | -69.3% | 0.00% | – |
Q1 2022 | $259,000 | -29.6% | 89,145 | +7.3% | 0.00% | – |
Q4 2021 | $368,000 | -39.2% | 83,056 | 0.0% | 0.00% | – |
Q3 2021 | $605,000 | -17.3% | 83,056 | +11.1% | 0.00% | – |
Q2 2021 | $732,000 | +13.0% | 74,777 | +36.8% | 0.00% | – |
Q1 2021 | $648,000 | +62.4% | 54,653 | +7.5% | 0.00% | – |
Q4 2020 | $399,000 | +15.3% | 50,826 | 0.0% | 0.00% | – |
Q3 2020 | $346,000 | +3.6% | 50,826 | +14.4% | 0.00% | – |
Q2 2020 | $334,000 | +9.5% | 44,439 | -8.3% | 0.00% | – |
Q1 2020 | $305,000 | -58.5% | 48,467 | +0.0% | 0.00% | – |
Q4 2019 | $735,000 | +47.6% | 48,450 | 0.0% | 0.00% | – |
Q3 2019 | $498,000 | -21.9% | 48,450 | +12.1% | 0.00% | – |
Q2 2019 | $638,000 | +21.1% | 43,202 | +35.0% | 0.00% | – |
Q1 2019 | $527,000 | +612.2% | 31,997 | +146.9% | 0.00% | – |
Q4 2018 | $74,000 | – | 12,961 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 6,758,204 | $49,200,000 | 11.16% |
Aquilo Capital Management, LLC | 3,155,082 | $22,969,000 | 4.17% |
GREAT POINT PARTNERS LLC | 1,170,000 | $8,518,000 | 1.98% |
Casdin Capital, LLC | 3,901,589 | $28,404,000 | 0.71% |
Alphabet Inc. | 3,339,138 | $24,309,000 | 0.58% |
Bleichroeder LP | 434,400 | $3,162,000 | 0.51% |
Palo Alto Investors LP | 432,300 | $3,147,000 | 0.19% |
Integral Health Asset Management, LLC | 90,000 | $655,000 | 0.19% |
Orbimed Advisors | 1,892,953 | $13,781,000 | 0.15% |
HARVARD MANAGEMENT CO INC | 332,610 | $2,421,000 | 0.14% |